I to kliniske forsøg med patienter med komplicerede intraabdominale infektioner (N = 962) var appendix (62%) det mest almindelige anatomiske infektionssted hos mikrobiologisk evaluerbare Doribax- behandlede patienter.
In two clinical trials of patients with complicated intra-abdominal infections (N=962) the most common anatomical site of infection in microbiologically-evaluable Doribax-treated patients was the appendix (62%).